Is there a role for LHRH antagonists in prostate cancer?
Goodman
Oscar B
OB
Department of Clinical Oncology, Nevada Cancer Institute, Las Vegas, Nevada, USA.
D018931:Antineoplastic Agents, Hormonal / Q000627:therapeutic use*; D007987:Gonadotropin-Releasing Hormone / Q000037:antagonists & inhibitors*; D006801:Humans; D008297:Male; D011471:Prostatic Neoplasms / Q000188:drug therapy* / Q000378:metabolism
D018931:Antineoplastic Agents, Hormonal; D007987:Gonadotropin-Releasing Hormone